CLSA Downgrades Altera (ALTR) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Altera (ALTR) PT Trimmed to $33 at Northland Capital Markets
January 23, 2015 8:36 AM ESTNorthland Capital Markets analyst Gus Richard reiterated a Market Perform rating and cut his price target on Altera (NASDAQ: ALTR) to $33.00 (from $38.00) following in-line Q4 results.
Richard commented, "ALTR reported in-line revenue and weak gross margin; EPS beat by $0.02 on a lower... More
